Millipore Sigma Vibrant Logo

411543 Mouse Anti-Human IgG₁, Fc Fragment Specific (HP6069) Biotin Conjugate

411543
View Pricing & Availability

Overview

Replacement Information

Pricing & Availability

Catalog Number AvailabilityPackaging Qty/Pack Price Quantity
411543-200UG
Retrieving availability...
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Plastic ampoule 200 μg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity is a multiple of
      Maximum Quantity is
      Upon Order Completion More Information
      You Saved ()
       
      Request Pricing
      Description
      Catalogue Number411543
      Brand Family Calbiochem®
      References
      ReferencesHamilton, R.G. 1990. Ann. Biol. Clin. 48, 473.
      Fasullo, F.J., et al. 1989. Clin. Chem. 35, 364.
      Hamilton, R.G. 1987. Clin. Chem. 33, 1707.
      Jefferis, R., et al. 1986. Immunol. Letters 10, 223.
      Product Information
      FormLiquid
      FormulationIn PBS, 1% BSA, pH 7.4.
      PreservativeNone
      Quality LevelMQ100
      Applications
      Application ReferencesCross-Reactivity, Myeloma Proteins Fasullo, F.J., et al. 1989. Clin. Chem. 35, 364. Jefferis, R., et al. 1986. Immunol. Letters 10, 223. Cross-Reactivity, Chimeric Antibodies Hamilton, R.G. 1990. Ann. Biol. Clin. 48, 473.
      Key Applications Enzyme Immunoassay
      Application NotesEnzyme Immunoassay (1:500-1:2000)
      Application CommentsAntibody should be titrated for optimal results in individual systems.

      Cross-reactivity by ELISA against human myeloma proteins:
      Human IgG1: 100%
      Human IgG2: ≤0.1%
      Human IgG3: ≤0.2%
      Human IgG4: ≤0.1%
      Human IgM: ≤0.1%
      Human IgA: ≤0.1%
      Human IgE: ≤0.1%

      Cross-reactivity by ELISA against chimeric antibodies:
      Human IgG1: 100%
      Human IgG2: <0.02%
      Human IgG3: <0.02%
      Human IgG4: <0.02%
      Human IgM: <0.02%
      Human IgA: <0.01%
      Human IgE: <0.001%
      Biological Information
      CloneHP6069
      HostMouse
      IsotypeIgG
      Antibody TypeMonoclonal Antibody
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      Mouse Anti-Human IgG₁, Fc Fragment Specific (HP6069) Biotin Conjugate SDS

      Title

      Safety Data Sheet (SDS) 

      Mouse Anti-Human IgG₁, Fc Fragment Specific (HP6069) Biotin Conjugate Certificates of Analysis

      TitleLot Number
      411543

      References

      Reference overview
      Hamilton, R.G. 1990. Ann. Biol. Clin. 48, 473.
      Fasullo, F.J., et al. 1989. Clin. Chem. 35, 364.
      Hamilton, R.G. 1987. Clin. Chem. 33, 1707.
      Jefferis, R., et al. 1986. Immunol. Letters 10, 223.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision06-August-2007 RFH
      ApplicationEnzyme Immunoassay (1:500-1:2000)
      DescriptionPurified mouse monoclonal antibody conjugated to biotin. Recognizes human IgG1 Fc fragment.
      BackgroundThe HP series of murine human Ig-specific monoclonal antibodies was produced from documented hybridoma cell lines that were developed at the Centers for Disease Control in Atlanta, Georgia. Laboratory analysis of each monoclonal antibody lot is performed in two stages during the production of ascites. First, the cell culture medium is analyzed for the presence and relative amount of human Ig-specific antibody by ELISA before injection of cells into mice. Second, collected ascites are analyzed for potency and antibody specificity using ELISA and isoelectric focusing (IEF), often in combination with an affinity immunoblot. For more information, the Calbiochem® technical monograph, The Human IgG Subclasses, is available free of charge.
      HostMouse
      CloneHP6069
      IsotypeIgG
      FormLiquid
      FormulationIn PBS, 1% BSA, pH 7.4.
      Concentration Label Please refer to vial label for lot-specific concentration
      PreservativeNone
      CommentsAntibody should be titrated for optimal results in individual systems.

      Cross-reactivity by ELISA against human myeloma proteins:
      Human IgG1: 100%
      Human IgG2: ≤0.1%
      Human IgG3: ≤0.2%
      Human IgG4: ≤0.1%
      Human IgM: ≤0.1%
      Human IgA: ≤0.1%
      Human IgE: ≤0.1%

      Cross-reactivity by ELISA against chimeric antibodies:
      Human IgG1: 100%
      Human IgG2: <0.02%
      Human IgG3: <0.02%
      Human IgG4: <0.02%
      Human IgM: <0.02%
      Human IgA: <0.01%
      Human IgE: <0.001%
      Storage -20°C
      Avoid freeze/thaw
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
      Toxicity Standard Handling
      ReferencesHamilton, R.G. 1990. Ann. Biol. Clin. 48, 473.
      Fasullo, F.J., et al. 1989. Clin. Chem. 35, 364.
      Hamilton, R.G. 1987. Clin. Chem. 33, 1707.
      Jefferis, R., et al. 1986. Immunol. Letters 10, 223.
      Application referencesCross-Reactivity, Myeloma Proteins Fasullo, F.J., et al. 1989. Clin. Chem. 35, 364. Jefferis, R., et al. 1986. Immunol. Letters 10, 223. Cross-Reactivity, Chimeric Antibodies Hamilton, R.G. 1990. Ann. Biol. Clin. 48, 473.